Filtered By:
Infectious Disease: COVID-19
This page shows you your search results in order of date. This is page number 16.
Order by Relevance | Date
Total 15791 results found since Jan 2013.
IJERPH, Vol. 20, Pages 6493: Trends in Prescription Chronic Pain Medication Use before and during the First Wave of the COVID-19 Pandemic in Qu & eacute;bec, Canada: An Interrupted Time Series Analysis
Conclusion: While the occurrence of the first wave did have an impact on opioid use among people living with chronic pain, access to and use of opioids appear to have returned to normal before the end of the first wave of COVID-19.
Source: International Journal of Environmental Research and Public Health - August 1, 2023 Category: Environmental Health Authors: Gwena ëlle De Clifford-Faugère Hermine Lore Nguena Nguefack Manon Choini ère M. Gabrielle Pag é Lucie Blais Line Gu énette Marc Dorais Ana ïs Lacasse Tags: Article Source Type: research
Exercise behavior, practice, injury, and symptoms of respiratory tract infection of 502 Brazilian adults during lockdown oscillations in two years (2021 –2022) of the COVID-19 pandemic
ConclusionAfter two years of the COVID-19 pandemic (2021 –2022), with periods of lockdown, there were low reports of injuries and pain symptoms after exercising on the return to physical exercise practices of running and strength training. However, the restrictions negatively affected the exercise behavior due to respiratory tract symptoms of COVID-19 a nd a reduction in training intensity, performed without any professional or technical supervision. The participants reported the use of a fabric or surgical mask for the prevention of COVID-19, and an increased feeling of anxiety. The reasons given for practicing physical...
Source: BMC Sports Science, Medicine and Rehabilitation - August 1, 2023 Category: Sports Medicine Source Type: research
Post-COVID syndrome and pain perception in outpatients with COVID-19
CONCLUSIONS: We suggest physical pain and inactivity symptoms in patients with COVID regressed in the 3rd month.PMID:37522703 | DOI:10.26355/eurrev_202307_33162
Source: European Review for Medical and Pharmacological Sciences - July 31, 2023 Category: Drugs & Pharmacology Authors: A Ta ş M Balo ğlu Source Type: research
Effect of definitive hypo-fractionated radiotherapy concurrent with weekly cisplatin in locally advanced squamous cell carcinoma of the head and neck
In this study, we aimed to determine whether hypo-fractionated intensity-modulated radiotherapy (hypo-IMRT) with concurrent chemotherapy was practical, effective, and could achieve acceptable tumor control rates for squamous cell carcinoma of the head and neck (SCCHN). We enrolled 62 patients with high-risk stage II, stage III, and IVA SCCHN who received hypo-IMRT (62.5 Gy in 25 fractions over 5 weeks 2.5Gy/fraction with weekly cisplatin 40 mg/m2). Our primary endpoint was to assess acute toxicity, while our secondary endpoints were late toxicity, loco-regional control, disease-free survival, and overall survival. The perc...
Source: Journal of Medicine and Life - July 31, 2023 Category: General Medicine Authors: Nora Abdelhafiz Doaa Mahmoud Mohamed Gad Hoda Essa Aiat Morsy Source Type: research
Post-COVID syndrome and pain perception in outpatients with COVID-19
CONCLUSIONS: We suggest physical pain and inactivity symptoms in patients with COVID regressed in the 3rd month.PMID:37522703 | DOI:10.26355/eurrev_202307_33162
Source: European Review for Medical and Pharmacological Sciences - July 31, 2023 Category: Drugs & Pharmacology Authors: A Ta ş M Balo ğlu Source Type: research
Effect of definitive hypo-fractionated radiotherapy concurrent with weekly cisplatin in locally advanced squamous cell carcinoma of the head and neck
In this study, we aimed to determine whether hypo-fractionated intensity-modulated radiotherapy (hypo-IMRT) with concurrent chemotherapy was practical, effective, and could achieve acceptable tumor control rates for squamous cell carcinoma of the head and neck (SCCHN). We enrolled 62 patients with high-risk stage II, stage III, and IVA SCCHN who received hypo-IMRT (62.5 Gy in 25 fractions over 5 weeks 2.5Gy/fraction with weekly cisplatin 40 mg/m2). Our primary endpoint was to assess acute toxicity, while our secondary endpoints were late toxicity, loco-regional control, disease-free survival, and overall survival. The perc...
Source: Journal of Medicine and Life - July 31, 2023 Category: General Medicine Authors: Nora Abdelhafiz Doaa Mahmoud Mohamed Gad Hoda Essa Aiat Morsy Source Type: research
Post-COVID syndrome and pain perception in outpatients with COVID-19
CONCLUSIONS: We suggest physical pain and inactivity symptoms in patients with COVID regressed in the 3rd month.PMID:37522703 | DOI:10.26355/eurrev_202307_33162
Source: European Review for Medical and Pharmacological Sciences - July 31, 2023 Category: Drugs & Pharmacology Authors: A Ta ş M Balo ğlu Source Type: research
Effect of definitive hypo-fractionated radiotherapy concurrent with weekly cisplatin in locally advanced squamous cell carcinoma of the head and neck
In this study, we aimed to determine whether hypo-fractionated intensity-modulated radiotherapy (hypo-IMRT) with concurrent chemotherapy was practical, effective, and could achieve acceptable tumor control rates for squamous cell carcinoma of the head and neck (SCCHN). We enrolled 62 patients with high-risk stage II, stage III, and IVA SCCHN who received hypo-IMRT (62.5 Gy in 25 fractions over 5 weeks 2.5Gy/fraction with weekly cisplatin 40 mg/m2). Our primary endpoint was to assess acute toxicity, while our secondary endpoints were late toxicity, loco-regional control, disease-free survival, and overall survival. The perc...
Source: Journal of Medicine and Life - July 31, 2023 Category: General Medicine Authors: Nora Abdelhafiz Doaa Mahmoud Mohamed Gad Hoda Essa Aiat Morsy Source Type: research
Post-COVID syndrome and pain perception in outpatients with COVID-19
CONCLUSIONS: We suggest physical pain and inactivity symptoms in patients with COVID regressed in the 3rd month.PMID:37522703 | DOI:10.26355/eurrev_202307_33162
Source: European Review for Medical and Pharmacological Sciences - July 31, 2023 Category: Drugs & Pharmacology Authors: A Ta ş M Balo ğlu Source Type: research
Effect of definitive hypo-fractionated radiotherapy concurrent with weekly cisplatin in locally advanced squamous cell carcinoma of the head and neck
In this study, we aimed to determine whether hypo-fractionated intensity-modulated radiotherapy (hypo-IMRT) with concurrent chemotherapy was practical, effective, and could achieve acceptable tumor control rates for squamous cell carcinoma of the head and neck (SCCHN). We enrolled 62 patients with high-risk stage II, stage III, and IVA SCCHN who received hypo-IMRT (62.5 Gy in 25 fractions over 5 weeks 2.5Gy/fraction with weekly cisplatin 40 mg/m2). Our primary endpoint was to assess acute toxicity, while our secondary endpoints were late toxicity, loco-regional control, disease-free survival, and overall survival. The perc...
Source: Journal of Medicine and Life - July 31, 2023 Category: General Medicine Authors: Nora Abdelhafiz Doaa Mahmoud Mohamed Gad Hoda Essa Aiat Morsy Source Type: research
